Current Perspectives on Severe Drug Eruption.
Zhang J, Lei Z, Xu C, Zhao J, Kang X.
Clin Rev Allergy Immunol. 2021 Dec;61(3):282-298. doi: 10.1007/s12016-021-08859-0. Epub 2021 Jul 17.
[Drug eruption].
Tareen A, Bygum A.
Ugeskr Laeger. 2018 Apr 16;180(16):V10170746.
A Review of Fixed Drug Eruption with a Special Focus on Generalized Bullous Fixed Drug Eruption.
Anderson HJ, Lee JB.
Medicina (Kaunas). 2021 Sep 1;57(9):925. doi: 10.3390/medicina57090925.
[Exanthematic drug eruption].
Ziemer M, Livingstone E.
Pathologie (Heidelb). 2025 Mar;46(2):90-100. doi: 10.1007/s00292-025-01418-w. Epub 2025 Feb 18.
Fixed drug eruption.
Chou YJ, Chang HC.
CMAJ. 2022 Aug 2;194(29):E1036. doi: 10.1503/cmaj.220049.
Dapsone-associated fixed drug eruption.
Garcia D, Cohen PR.
Expert Rev Clin Pharmacol. 2017 Jul;10(7):717-725. doi: 10.1080/17512433.2017.1322508. Epub 2017 Apr 28.
Bullous Drug Reactions.
Mockenhaupt M.
Acta Derm Venereol. 2020 Feb 12;100(5):adv00057. doi: 10.2340/00015555-3408.
Ecstasy-induced fixed drug eruption.
Barbier O, Galadari A, Milpied B, Sanchez P, Kassab S, Goncalves R, Darrigade AS.
Contact Dermatitis. 2022 Sep;87(3):280-281. doi: 10.1111/cod.14132. Epub 2022 Apr 29.
Terbinafine-induced lichenoid drug eruption.
Zheng Y, Zhang J, Chen H, Lai W, Maibach HI.
Cutan Ocul Toxicol. 2017 Mar;36(1):101-103. doi: 10.3109/15569527.2016.1160101. Epub 2016 Mar 30.
Generalized Bullous Fixed Drug Eruption.
Chai L, Liu ZH.
Dermatitis. 2023 Sep-Oct;34(5):364-365. doi: 10.1089/derm.2022.0088. Epub 2023 Mar 28.
